Inventor · disambiguated record
Maureen Howard
Also filed as: HOWARD MAUREEN · HOWARD MAUREEN C
21 granted patents·7 pending applications·136 citations·filing 1995–2023
95Inventor score
Top patents by PatentIndex Score
28 records- 0198US11518806B2Methods for treating cancer by achieving therapeutically effective doses of anti-CD47 antibodyUNIV LELAND STANFORD JUNIOR·Filed 2022·Granted Dec 6, 2022·6 cites·34 claims
- 0297US11136391B2Methods for treating cancer by achieving therapeutically effective doses of anti-CD47 antibodyUNIV LELAND STANFORD JUNIOR·Filed 2020·Granted Oct 5, 2021·9 cites·17 claims
- 0396US11603404B2Methods for treating cancer by achieving therapeutically effective doses of anti-CD47 antibodyUNIV LELAND STANFORD JUNIOR·Filed 2022·Granted Mar 14, 2023·3 cites·36 claims
- 0496US9623079B2Methods for achieving therapeutically effective doses of anti-CD47 agents for treating cancerUNIV LELAND STANFORD JUNIOR·Filed 2014·Granted Apr 18, 2017·26 cites·12 claims
- 0594US10301387B2Methods for achieving therapeutically effective doses of anti-CD47 agentsUNIV LELAND STANFORD JUNIOR·Filed 2017·Granted May 28, 2019·11 cites·15 claims
- 0686US12258403B2Methods for treating myeloma by achieving therapeutically effective doses of anti-CD47 antibodyUNIV LELAND STANFORD JUNIOR·Filed 2023·Granted Mar 25, 2025·0 cites·19 claims
- 0781US5837232AUse of an interleukin-10 antagonist to treat a B cell mediated autoimmune disorderSCHERING CORP·Filed 1995·Granted Nov 17, 1998·30 cites·7 claims
- 0880US12258399B2Methods for achieving therapeutically effective doses of anti-CD47 agentsUNIV LELAND STANFORD JUNIOR·Filed 2021·Granted Mar 25, 2025·0 cites·18 claims
- 0980US7678891B2Antibodies that bind CCX-CKR2CHEMOCENTRYX INC·Filed 2006·Granted Mar 16, 2010·3 cites·18 claims
- 1073US11104731B2Compositions for achieving therapeutically effective doses of anti-CD47 agentsUNIV LELAND STANFORD JUNIOR·Filed 2019·Granted Aug 31, 2021·0 cites·2 claims
- 1173US7253007B2Compositions and methods for detecting and treating diseases and conditions related to chemokine receptorsCHEMOCENTRYX INC·Filed 2003·Granted Aug 7, 2007·5 cites·14 claims
- 1270US7442512B2Compositions and methods for detecting and treating diseases and conditions related to chemokine receptorsCHEMOCENTRYX INC·Filed 2002·Granted Oct 28, 2008·5 cites·22 claims
- 1363US7777009B2Compositions for detecting and treating diseases and conditions related to chemokine receptorsCHEMOCENTRYX INC·Filed 2007·Granted Aug 17, 2010·0 cites·3 claims
- 1462US7871619B2Compositions and methods for detecting and treating diseases and conditions related to chemokine receptorsCHEMOCENTRYX INC·Filed 2004·Granted Jan 18, 2011·1 cites·10 claims
- 1560US5833976AUse of interleukin-10 (IL-10) to treat endotoxin- or superantigen-induced toxicitySCHERING CORP·Filed 1995·Granted Nov 10, 1998·9 cites·25 claims
- 1657US5837293AUse of interleukin-10 analogs for antagonists to treat endotoxin- or superantigen-induced toxicitySCHERING CORP·Filed 1995·Granted Nov 17, 1998·9 cites·18 claims
- 1754US7361329B2Compositions for inducing an immune responseCHEMOCENTRYX INC·Filed 2001·Granted Apr 22, 2008·0 cites·36 claims
- 1854US2003215460A1Methods and compositions for inducing an immune responseFiled 2002·Application pending·0 cites
- 1952US6171590B1Chemokine receptor peptide for inducing an immune responseCORIXA CORP·Filed 1998·Granted Jan 9, 2001·10 cites·42 claims
- 2052US2011052589A1Compositions and methods for detecting and treating diseases and conditions related to chemokine receptorsCHEMOCENTRYX INC·Filed 2010·Application pending·0 cites
- 2150US2010247540A1Methods and Compositions For Modulating AngiogenesisCHEMOCENTRYX INC·Filed 2009·Application pending·0 cites
- 2249US7413866B2Compositions and methods for detecting and treating diseases and conditions related to chemokine receptorsCHEMOCENTRYX INC·Filed 2003·Granted Aug 19, 2008·0 cites·2 claims
- 2347US6207155B1Method of eosinophil depletion with antibody to CCR 3 receptorSCHERING CORP·Filed 1998·Granted Mar 27, 2001·9 cites·10 claims
- 2446US8637043B2Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereofSCHALL THOMAS J·Filed 2005·Granted Jan 28, 2014·0 cites·11 claims
- 2543US2011165164A1Compositions and methods for detecting and treating diseases and conditions related to chemokine receptorsCHEMOCENTRYX INC·Filed 2010·Application pending·0 cites
- 2643US2010278820A1Reagents that bind ccx-ckr2CHEMOCENTRYX INC·Filed 2010·Application pending·0 cites
- 2741US2001006942A1Chemokine receptor peptide vaccines for treatment and prevention of diabetesFiled 2001·Application pending·0 cites
- 2839US2005214287A1Methods and compositions for modulating angiogenesisCHEMOCENTRYX INC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Maureen Howard files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →